Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBelluscura Regulatory News (BELL)

Share Price Information for Belluscura (BELL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.00
Bid: 15.00
Ask: 17.00
Change: 0.00 (0.00%)
Spread: 2.00 (13.333%)
Open: 16.00
High: 16.00
Low: 16.00
Prev. Close: 16.00
BELL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update re proposed placing of CLNs

24 Jun 2024 07:00

RNS Number : 4902T
Belluscura PLC
24 June 2024
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATIONS (EU) NO. 596/2014 WHICH HAS BEEN INCORPORATED INTO UK LAW BY THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

24 June 2024

 

Belluscura plc

("Belluscura" or the "Company")

Update re proposed placing of convertible loan notes

 

Subscription for new ordinary shares to raise £300,000

 

Total voting rights

 

LONDON, U.K. AND PLANO, TX, U.S. (24 June 2024). Belluscura plc (AIM: BELL), announced on 12 June 2024 a proposed placing of convertible loan notes. The Company has received significant interest in, and demand for, the proposed placing from new and existing investors and anticipates being able to provide an update as to final terms, including the issue size, shortly.

 

Details of subscription for new ordinary shares

 

Separately, an investor has approached the Company expressing an interest in subscribing for new ordinary shares of 1 penny each in the Company ("Ordinary Shares"). Consequently, utilising the Directors' existing share authorities to issue Ordinary Shares for cash on a non-pre-emptive basis, the Company has raised gross proceeds of £300,00.00 through a subscription by such investor for, and the allotment and issue by the Company of, 2,000,000 new Ordinary Shares (the "Subscription Shares") at an issue price of 15 pence (the "Subscription Price") per Subscription Share (the "Subscription").

 

The net proceeds of the Subscription will be used for working capital purposes. The Subscription Price of 15 pence per Subscription Share represents a discount of 7.7 per cent. to the closing mid-market price of 16.25 pence per existing Ordinary Share on 21 June 2024 (being the last business day prior to this announcement).

 

Application for Admission

 

Application has been made for the Subscription Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and that dealings will commence at 8.00 a.m. on or around 25 June 2024. Once issued, the Subscription Shares will rank pari passu with the Company's existing Ordinary Shares.

 

Total voting rights

 

Following Admission, the enlarged issued share capital of the Company will comprise 167,032,567 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. Consequently, 167,032,567 is the figure which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

For further information please contact:

Belluscura plc

Tel: +44 (0)20 3128 8100

Adam Reynolds, Chairman

Robert Rauker, Chief Executive Officer

Simon Neicheril, Chief Financial Officer

SPARK Advisory Partners Limited - Nominated Adviser

Tel: +44 (0)20 3368 3550

Neil Baldwin / Jade Bayat

Dowgate Capital Limited - Broker

Tel: +44 (0)20 3903 7715

Russell Cook / Nicholas Chambers

MHP Group - Financial PR & Investor Relations

Tel: +44 (0)20 3128 8100

Katie Hunt / Matthew Taylor

email: Belluscura@mhpgroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAEKDAFXLEAA
Date   Source Headline
27th Jun 20247:00 amRNSFinal Results
25th Jun 20243:34 pmRNSHolding(s) in Company
24th Jun 20247:00 amRNSUpdate re proposed placing of CLNs
14th Jun 20241:45 pmRNSPosting of Circular and Notice of General Meeting
12th Jun 20247:00 amRNSTrading update and proposed placing
17th Apr 20247:00 amRNSBelluscura Concert Party
11th Apr 202410:23 amRNSHolding(s) in Company
8th Apr 20241:15 pmRNSHolding(s) in Company
5th Apr 20243:48 pmRNSIssue of Equity
2nd Apr 20247:00 amRNSTrading Update
28th Mar 20247:00 amRNSTotal Voting Rights
8th Mar 20244:36 pmRNSOffer Closed
7th Mar 20248:30 amRNSCancellation of Listing and trading
4th Mar 20247:00 amRNSAcceptances level
26th Feb 20247:00 amRNSAcceptances level
22nd Feb 20243:00 pmRNSAcceptances level, issue of equity & AIM Admission
19th Feb 20247:00 amRNSAcceptances level & offer closing
15th Feb 20243:51 pmRNSAcceptances level, issue of equity & AIM Admission
13th Feb 20247:00 amRNSDistribution Agreement & New VP North America
13th Feb 20247:00 amRNSAcceptances Level
12th Feb 20241:44 pmGNWForm 8.3 - Belluscura PLC
9th Feb 20248:16 amRNSOffer becomes wholly unconditional
8th Feb 20243:31 pmRNSAcceptances level, issue of equity & AIM Admission
7th Feb 20244:20 pmRNSOffer Unconditional (subject to AIM Admission)
7th Feb 202411:13 amRNSForm 8.3 - Belluscura Plc
5th Feb 20241:30 pmRNSResult of General Meeting
5th Feb 20247:00 amRNSAcceptances received in respect of the Offer
2nd Feb 202411:24 amRNSForm 8 (OPD) Belluscura plc
2nd Feb 202411:18 amRNSForm 8 (OPD) TMT Acquisition plc
1st Feb 20246:16 pmRNSForm 8 (OPD) TMT Acquisition plc - Amended
1st Feb 20246:14 pmRNSForm 8 (OPD) Belluscura plc - Amended
1st Feb 20242:34 pmGNWForm 8.3 - Belluscura PLC
29th Jan 202411:42 amRNSForm 8.3 - Belluscura PLC
24th Jan 20246:24 pmRNSForm 8.3 - Belluscura PLC
24th Jan 20246:17 pmRNSForm 8.3 - Belluscura
24th Jan 20246:02 pmRNSForm 8.3 - Belluscura PLC - Replacement
24th Jan 20245:49 pmRNSForm 8.3 - Belluscura PLC
24th Jan 20243:25 pmRNSForm 8.3 - Belluscura plc
24th Jan 20243:14 pmRNSHolding(s) in Company
24th Jan 202410:45 amRNSForm 8.3 - Belluscura Plc
23rd Jan 20246:06 pmRNSForm 8.3 - Belluscura plc
23rd Jan 20245:39 pmRNSForm 8.3 - BELLUSCURA PLC
19th Jan 20241:30 pmRNSPosting of Offer Document and Circular
8th Jan 20241:01 pmGNWForm 8.3 - Belluscura PLC
22nd Dec 202312:10 pmRNSExtension to deadline for posting Offer Document
20th Dec 20237:00 amRNSChinese registration and Trading Update
19th Dec 20231:04 pmGNWForm 8.3 - Belluscura PLC
13th Dec 20232:43 pmGNWForm 8.3 - Belluscura PLC
12th Dec 20237:00 amRNSBelluscura Receives Approval in Singapore
28th Nov 20235:00 pmRNSExtension to deadline for posting Offer Document

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.